ランバート-イートン筋無力症候群治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST00305
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、ランバート-イートン筋無力症候群治療の世界市場について調査・分析し、ランバート-イートン筋無力症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（カリウムチャネル遮断薬（アミファンプリジン）、コリンエステラーゼ阻害薬（ピリドスチグミン）、免疫療法、静脈内免疫グロブリン、血漿交換）、用途別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界のランバート-イートン筋無力症候群治療市場動向
・主要企業別マーケットシェア
・ランバート-イートン筋無力症候群治療の種類別市場規模2014-2019
（カリウムチャネル遮断薬（アミファンプリジン）、コリンエステラーゼ阻害薬（ピリドスチグミン）、免疫療法、静脈内免疫グロブリン、血漿交換）
・ランバート-イートン筋無力症候群治療の用途別市場規模2014-2019
（病院、外来手術センター、その他）
・ランバート-イートン筋無力症候群治療の北米市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療の中国市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療の日本国内市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療の東南アジア市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療のインド市場：主要企業・種類別/用途別市場規模
・ランバート-イートン筋無力症候群治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Allergan, Plc.、Biomarin Pharmaceutical, Inc.、Catalyst Pharmaceuticals, Inc.、F. Hoffman-La Roche Ltd.、GlaxoSmithkline, Plc.、Jacobus Pharmaceutical Company, Inc.、Kawasumi Laboratories, Inc.、Merck & Co., Inc.、Mitsubishi Pharma Corporation）
・ランバート-イートン筋無力症候群治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder involving nerves and muscles that results in significant muscle weakness. It is often associated with certain types of cancer or other autoimmune disorders. It is caused by faulty nerve cells that fail to release sufficient amounts of acetylcholine, the chemical essential for the conduction of impulses between nerves and muscles. There are a number of treatments available for the disorder, but serious complications are possible.In 2018, the global Lambert-Eaton Myasthenic Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lambert-Eaton Myasthenic Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lambert-Eaton Myasthenic Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Allergan, Plc.
Biomarin Pharmaceutical, Inc.
Catalyst Pharmaceuticals, Inc.
F. Hoffman-La Roche Ltd.
GlaxoSmithkline, Plc.
Jacobus Pharmaceutical Company, Inc.
Kawasumi Laboratories, Inc.
Merck & Co., Inc.
Mitsubishi Pharma Corporation

Market segment by Type, the product can be split into
Potassium Channel Blockers (Amifampridine)
Cholinesterase Inhibitor (Pyridostigmine)
Immune Therapy
Intravenous Immunoglobulin
Plasmapheresis

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lambert-Eaton Myasthenic Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lambert-Eaton Myasthenic Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lambert-Eaton Myasthenic Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Potassium Channel Blockers (Amifampridine)
1.4.3 Cholinesterase Inhibitor (Pyridostigmine)
1.4.4 Immune Therapy
1.4.5 Intravenous Immunoglobulin
1.4.6 Plasmapheresis
1.5 Market by Application
1.5.1 Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lambert-Eaton Myasthenic Syndrome Treatment Market Size
2.2 Lambert-Eaton Myasthenic Syndrome Treatment Growth Trends by Regions
2.2.1 Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Regions (2019-2025)
2.2.2 Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Lambert-Eaton Myasthenic Syndrome Treatment Market Size by by Players
3.1.1 Global Lambert-Eaton Myasthenic Syndrome Treatment Revenue by by Players (2014-2019)
3.1.2 Global Lambert-Eaton Myasthenic Syndrome Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Lambert-Eaton Myasthenic Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Lambert-Eaton Myasthenic Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Lambert-Eaton Myasthenic Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
5.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in North America
5.3 North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
5.4 North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

6 Europe
6.1 Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
6.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in Europe
6.3 Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
6.4 Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

7 China
7.1 China Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
7.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in China
7.3 China Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
7.4 China Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

8 Japan
8.1 Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
8.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in Japan
8.3 Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
8.4 Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
9.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
9.4 Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

10 India
10.1 India Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
10.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in India
10.3 India Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
10.4 India Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size (2014-2019)
11.2 Lambert-Eaton Myasthenic Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type
11.4 Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application

12 International Players Profiles
12.1 Allergan, Plc.
12.1.1 Allergan, Plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.1.4 Allergan, Plc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019))
12.1.5 Allergan, Plc. Recent Development
12.2 Biomarin Pharmaceutical, Inc.
12.2.1 Biomarin Pharmaceutical, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.2.4 Biomarin Pharmaceutical, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.2.5 Biomarin Pharmaceutical, Inc. Recent Development
12.3 Catalyst Pharmaceuticals, Inc.
12.3.1 Catalyst Pharmaceuticals, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.3.4 Catalyst Pharmaceuticals, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.3.5 Catalyst Pharmaceuticals, Inc. Recent Development
12.4 F. Hoffman-La Roche Ltd.
12.4.1 F. Hoffman-La Roche Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.4.4 F. Hoffman-La Roche Ltd. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.4.5 F. Hoffman-La Roche Ltd. Recent Development
12.5 GlaxoSmithkline, Plc.
12.5.1 GlaxoSmithkline, Plc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.5.4 GlaxoSmithkline, Plc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.5.5 GlaxoSmithkline, Plc. Recent Development
12.6 Jacobus Pharmaceutical Company, Inc.
12.6.1 Jacobus Pharmaceutical Company, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.6.4 Jacobus Pharmaceutical Company, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.6.5 Jacobus Pharmaceutical Company, Inc. Recent Development
12.7 Kawasumi Laboratories, Inc.
12.7.1 Kawasumi Laboratories, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.7.4 Kawasumi Laboratories, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.7.5 Kawasumi Laboratories, Inc. Recent Development
12.8 Merck & Co., Inc.
12.8.1 Merck & Co., Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.8.4 Merck & Co., Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.8.5 Merck & Co., Inc. Recent Development
12.9 Mitsubishi Pharma Corporation
12.9.1 Mitsubishi Pharma Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lambert-Eaton Myasthenic Syndrome Treatment Introduction
12.9.4 Mitsubishi Pharma Corporation Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
12.9.5 Mitsubishi Pharma Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lambert-Eaton Myasthenic Syndrome Treatment Key Market Segments
Table Key Players Lambert-Eaton Myasthenic Syndrome Treatment Covered
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Potassium Channel Blockers (Amifampridine) Figures
Table Key Players of Potassium Channel Blockers (Amifampridine)
Figuer Cholinesterase Inhibitor (Pyridostigmine) Figures
Table Key Players of Cholinesterase Inhibitor (Pyridostigmine)
Figuer Immune Therapy Figures
Table Key Players of Immune Therapy
Figuer Intravenous Immunoglobulin Figures
Table Key Players of Intravenous Immunoglobulin
Figuer Plasmapheresis Figures
Table Key Players of Plasmapheresis
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Lambert-Eaton Myasthenic Syndrome Treatment Report Years Considered
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by by Players (2014-2019)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Share by by Players in 2018
Table Global Lambert-Eaton Myasthenic Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lambert-Eaton Myasthenic Syndrome Treatment Product/Solution/Service
Table Date of Enter into Lambert-Eaton Myasthenic Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Revenue Market Share by Application in 2018
Figure North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure China Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table China Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table China Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table China Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table China Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure India Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table India Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table India Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table India Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table India Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Figure Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lambert-Eaton Myasthenic Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lambert-Eaton Myasthenic Syndrome Treatment Market Share (2018-2019)
Table Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Type 2014-2019
Table Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Share by Application 2014-2019
Table Allergan, Plc. Company Details
Table Allergan, Plc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Allergan, Plc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Allergan, Plc. Recent Development
Table Biomarin Pharmaceutical, Inc. Company Details
Table Biomarin Pharmaceutical, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Biomarin Pharmaceutical, Inc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Biomarin Pharmaceutical, Inc. Recent Development
Table Catalyst Pharmaceuticals, Inc. Company Details
Table Catalyst Pharmaceuticals, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Catalyst Pharmaceuticals, Inc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Catalyst Pharmaceuticals, Inc. Recent Development
Table F. Hoffman-La Roche Ltd. Company Details
Table F. Hoffman-La Roche Ltd. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure F. Hoffman-La Roche Ltd. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table F. Hoffman-La Roche Ltd. Recent Development
Table GlaxoSmithkline, Plc. Company Details
Table GlaxoSmithkline, Plc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithkline, Plc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table GlaxoSmithkline, Plc. Recent Development
Table Jacobus Pharmaceutical Company, Inc. Company Details
Table Jacobus Pharmaceutical Company, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Jacobus Pharmaceutical Company, Inc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Jacobus Pharmaceutical Company, Inc. Recent Development
Table Kawasumi Laboratories, Inc. Company Details
Table Kawasumi Laboratories, Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Kawasumi Laboratories, Inc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Kawasumi Laboratories, Inc. Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Mitsubishi Pharma Corporation Company Details
Table Mitsubishi Pharma Corporation Revenue in Lambert-Eaton Myasthenic Syndrome Treatment Business 2014-2019 (Million US$)
Figure Mitsubishi Pharma Corporation Revenue Growth Rate in Lambert-Eaton Myasthenic Syndrome Treatment Business (2014-2019)
Table Mitsubishi Pharma Corporation Recent Development
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size Share by Regions in 2025
Figure North America Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lambert-Eaton Myasthenic Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Product in 2025
Table Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Lambert-Eaton Myasthenic Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

ハンター症候群治療の世界市場：市場規模・現状・予測

Global Hunter Syndrome Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04183 2019年9月2日 94Pages
※当調査レポートでは、ハンター症候群治療の世界市場について調査・分析し、ハンター症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他）...

クッシング症候群および末端肥大症の治療の世界市場：市場規模・現状・予測

Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04786 2019年9月2日 92Pages
※当調査レポートでは、クッシング症候群および末端肥大症の治療の世界市場について調査・分析し、クッシング症候群および末端肥大症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（グルココルチコイド受...

ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測

Global Wolff Parkinson White Syndrome Treatment Market Size, Status and Forecast 2019-2025
QYR9ST05080 2019年9月2日 99Pages
※当調査レポートでは、ウルフパーキンソンホワイト症候群の治療の世界市場について調査・分析し、ウルフパーキンソンホワイト症候群の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬、電気除細動、手術...

ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測

ドライアイ症候群の治療の世界市場：インサイト・予測

Global Dry Eye Syndrome Treatment Market Insights, Forecast to 2025
QYR9ST02420 2019年9月2日 116Pages
※本調査レポートでは、世界のドライアイ症候群の治療市場について調査・分析し、以下の構成でお届け致します。ドライアイ症候群の治療の種類別には、液滴、ジェル、液体ワイプ、眼軟膏、その他に、用途別には、病院、診療所、ホームに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中...

カルチノイド症候群管理の世界市場：市場規模・現状・予測

Global Carcinoid Syndrome Management Market Size, Status and Forecast 2019-2025
QYR9ST03601 2019年9月2日 90Pages
※当調査レポートでは、カルチノイド症候群管理の世界市場について調査・分析し、カルチノイド症候群管理の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、生物学的療法、肝動脈塞栓剤）、用途別（病院...

吸収不良症候群の世界市場：市場規模・現状・予測

Global Malabsorption Syndrome Market Size, Status and Forecast 2019-2025
QYR9ST05306 2019年9月2日 98Pages
※当調査レポートでは、吸収不良症候群の世界市場について調査・分析し、吸収不良症候群の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血液検査、イメージング研究）、用途別（製薬会社、病院、栄養クリニック...

吸収不良症候群の世界市場：市場規模・現状・予測

急性冠症候群（ACS）の世界市場：市場規模・現状・予測

Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2019-2025
QYR9ST05225 2019年9月2日 93Pages
※当調査レポートでは、急性冠症候群（ACS）の世界市場について調査・分析し、急性冠症候群（ACS）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（単独療法、併用療法）、用途別（病院、外来手術センター...

急性冠症候群（ACS）の世界市場：市場規模・現状・予測

ハンター症候群治療の世界市場：市場規模・現状・予測 Hunter syndrome or Mucopolysaccharidosis type 2 is an inherited genetic disorder caused by malfunctioning or missing enzyme. Hunter syndrome affects several parts of the body and shows symptoms such as large round cheeks, enlarged tongue, full lips, and broad nose. As the disorder advances by age, i…
クッシング症候群および末端肥大症の治療の世界市場：市場規模・現状・予測 Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …
ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測 Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測 Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
ドライアイ症候群の治療の世界市場：インサイト・予測 Dry eye syndrome occurs due to inappropriate formation of tears evaporating too quickly or dearth of tears to lubricate and nourish the eye. If left untreated, this condition can lead to pain, ulcers, scars on the cornea, and even loss of vision.The global Dry Eye Syndrome Treatment market is valued…